Game-changing companies

Share this article:
Game-changing companies
Game-changing companies

Addison Whitney

To download a PDF of this profile, click here

Company Profile

Addison Whitney is a global branding firm with a passion for building strong brands. We specialize in verbal and visual branding, brand strategy and research.

Addison Whitney Health is a specialized division of ­Addison Whitney and is a global leader in pharmaceutical and healthcare brand development. We are part of ­inVentiv Health, a large network of clinical, commercial and consulting companies. Through this network, we are able to provide best-in-class services that deliver extraordinary outcomes to pharmaceutical, life sciences and biotech clients.

Addison Whitney Health's collaborative approach ­merges our industry expertise with your business strategy to develop engaging brands for every audience. This approach extends to our relationships with the FDA, EMA, Health Canada and other regulatory authorities—assuring your brand will gain approval and exist successfully in a clinical and commercial world. We deliver healthcare and pharmaceutical brands that integrate creativity, business strategy, trademark viability and regulatory compliances.

Services and Offerings

Verbal Branding
• Brand Name Development (Corporate/Product)
• REMS and Program Branding
• INN/USAN (Generic Name) Development
• Clinical Trial Naming
• Global Trademark Prescreening
• Global Linguistic Evaluation

Visual Branding
• Corporate, Product and Clinical Trial Logo Design
• Packaging Artwork
• Marketing Collateral and Tradeshow Materials
• Standards Program Development

Brand Strategy
• Brand Assessment
• Scientific Branding
• Brand Positioning and Messaging
• Brand Architecture
• Portfolio Nomenclature

Research & Analysis
• Brand Discovery/Positioning ­Research
• Name Validation Research (Regulatory & Marketing)
• Logo Validation Research (Regulatory & Marketing)
• Regulatory Name Submission Documents and ­Consulting

What will be the game-changing trend over the next five years?

In the next five years, the growing trend with biotech and pharmaceutical companies will continue to focus on bringing biosimilars to market.

With much debate on how non-proprietary drug nomenclature for biosimilars will be adopted, there will be even more focus on how manufacturers will brand their biosimilars. There's never been a more exciting time to be a branding firm—to help shape and differentiate these new brands as they compete for market share. The opportunity to create an impactful brand at more aggressive pricing to compete with current therapies will shape healthcare for the next generation.

Address 11525 N. Community House Rd., Suite 400, Charlotte, NC 28277 Phone 888.997.4155 Website www.addisonwhitneyhealth.com New Business Contact Brannon Cashion, Global President, 704.697.4022, bcashion@addisonwhitney.com Year Founded 1991 Employees 50 Holding Company inVentiv Health Office Locations Charlotte (headquarters), New York, Seattle, London, Munich, Tokyo

Page 2 of 11
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?